RNA Therapeutics in Skin Cancer: Emerging Strategies, Challenges, and Future Perspectives

Open Access

Issue		BIO Web Conf. Volume 233, 2026 9^th International Conference on Advances in Biosciences and Biotechnology: Emerging Innovations in Biomedical and Bioengineering Sciences (ICABB 2026)


Article Number		01019
Number of page(s)		10
Section		Biomedical and Health Innovations
DOI		https://doi.org/10.1051/bioconf/202623301019
Published online		23 April 2026

Barata, P., Sood, A. K., & Hong, D. S. (2016). RNA-targeted therapeutics in cancer clinical trials: Current status and future directions. Cancer Treatment Reviews, 50, 35–47. https://doi.org/10.1016/j.ctrv.2016.08.004 [Google Scholar]
Bidram, M., Zhao, Y., Shebardina, N. G., Baldin, A. V., Bazhin, A. V., Ganjalikhany, M. R., Zamyatnin, A. A., Jr, & Ganjalikhani-Hakemi, M. (2021). mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients. Vaccines, 9(10), 1060. https://doi.org/10.3390/vaccines9101060 [Google Scholar]
Chai, E. S. X., Cai, S. C. S., Chun, Y. Y., Tan, Y., Tan, T. T., & Tey, H. L. (2024). The potential of RNA therapeutics in dermatology. Annals of the Academy of Medicine, Singapore, 53(2), 113–116. https://doi.org/10.47102/annals-acadmedsg.2023316 [Google Scholar]
Chi, X., Gatti, P., & Papoian, T. (2017). Safety of antisense oligonucleotide and siRNA-based therapeutics. Drug Discovery Today, 22(5), 823–833. https://doi.org/10.1016/j.drudis.2017.01.013 [Google Scholar]
Cullen, J. K., Simmons, J. L., Parsons, P. G., & Boyle, G. M. (2020). Topical treatments for skin cancer. Advanced Drug Delivery Reviews, 153, 54–64. https://doi.org/10.1016/j.addr.2019.11.002 [Google Scholar]
Deng, Y., Wang, C. C., Choy, K. W., Du, Q., Chen, J., Wang, Q., Li, L., Chung, T. K., & Tang, T. (2014). Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies. Gene, 538(2), 217–227. https://doi.org/10.1016/j.gene.2013.12.019 [Google Scholar]
Fien, S. M., & Oseroff, A. R. (2007). Photodynamic Therapy for Non-Melanoma Skin Cancer. Journal of the National Comprehensive Cancer Network, 5(5), 531–540. https://doi.org/10.6004/jnccn.2007.0046 [Google Scholar]
Garbutcheon-Singh, K. B., & Veness, M. J. (2019). The role of radiotherapy in the management of nonmelanoma skin cancer. Australasian Journal of Dermatology, 60(4), 265–272. https://doi.org/10.1111/ajd.13025 [Google Scholar]
Hyeraci, M., Papanikolau, E. S., Grimaldi, M., Ricci, F., Pallotta, S., Monetta, R., Minato, Y. A., Di Lella, G., Galdo, G., Abeni, D., Fania, L., & Dellambra, E. (2023). Systemic Photoprotection in Melanoma and Non-Melanoma Skin Cancer. Biomolecules, 13(7), 1067. https://doi.org/10.3390/biom13071067 [Google Scholar]
Kirby, J. S., & Miller, C. J. (2010). Intralesional chemotherapy for nonmelanoma skin cancer: a practical review. Journal of the American Academy of Dermatology, 63(4), 689–702. https://doi.org/10.1016/j.jaad.2009.09.048 [Google Scholar]
Laikova, K. V., Oberemok, V. V., Krasnodubets, A. M., Gal'chinsky, N. V., Useinov, R. Z., Novikov, I. A., Temirova, Z. Z., Gorlov, M. V., Shved, N. A., Kumeiko, V. V., Makalish, T. P., Bessalova, E. Y., Fomochkina, I. I., Esin, A. S., Volkov, M. E., & Kubyshkin, A. V. (2019). Advances in the Understanding of Skin Cancer: Ultraviolet Radiation, Mutations, and Antisense Oligonucleotides as Anticancer Drugs. Molecules (Basel, Switzerland), 24(8), 1516. https://doi.org/10.3390/molecules24081516 [Google Scholar]
Lane, J. E., & Kent, D. E. (2005). Surgical Margins in the Treatment of Nonmelanoma Skin Cancer and Mohs Micrographic Surgery. Current Surgery, 62(5), 518-526. https://doi.org/10.1016/j.cursur.2005.01.003 [Google Scholar]
Lang, P. G. (2004). The role of Mohs’ micrographic surgery in the management of skin cancer and a perspective on the management of the surgical defect. Clinics in Plastic Surgery, 31(1), 5–31. https://doi.org/10.1016/s0094-1298(03)00096-8 [Google Scholar]
Lauters, R., Brown, A. D., & Harrington, K. A. (2024). Melanoma: Diagnosis and Treatment. American family physician, 110(4), 367–377 [Google Scholar]
Linares, M. A., Zakaria, A., & Nizran, P. (2015). Skin Cancer. Primary care, 42(4), 645–659. https://doi.org/10.1016/j.pop.2015.07.006 [Google Scholar]
Miele, E., Spinelli, G. P., Miele, E., Di Fabrizio, E., Ferretti, E., Tomao, S., & Gulino, A. (2012). Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy. International journal of nanomedicine, 7, 3637–3657. https://doi.org/10.2147/IJN.S23696 [Google Scholar]
Nuraiziah Johari. (2024, February 27). The potential of RNA therapeutics in dermatology - Annals Singapore. Annals Singapore. https://annals.edu.sg/the-potential-of-rna-therapeutics-in-dermatology/ [Google Scholar]
Veness, M., & Richards, S. (2003). Role of modern radiotherapy in treating skin cancer. Australasian Journal of Dermatology, 44(3), 159–168. https://doi.org/10.1046/j.1440-0960.2003.06711.x [Google Scholar]
Vishweshwaraiah, Y. L., & Dokholyan, N. V. (2022). mRNA vaccines for cancer immunotherapy. Frontiers in immunology, 13, 1029069. https://doi.org/10.3389/fimmu.2022.1029069 [Google Scholar]
Wang, M., Gao, X., & Zhang, L. (2024). Recent global patterns in skin cancer incidence, mortality, and prevalence. Chinese Medical Journal, 138(2), 10.1097/CM9.0000000000003416. https://doi.org/10.1097/CM9.0000000000003416 [Google Scholar]
Zhong, X., Zhang, D., Xiong, M., & Zhang, L. (2016). Noncoding RNA for Cancer Gene Therapy. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 209, 51–60. https://doi.org/10.1007/978-3-319-42934-24 [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.